Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Institut du Cancer de Montpellier - Val d'Aurelle
University of Nebraska
Tanabe Pharma America, Inc.
Massive Bio, Inc.
Jonsson Comprehensive Cancer Center
Turning Point Therapeutics, Inc.
Nanjing First Hospital, Nanjing Medical University
Universidad Nacional Autonoma de Mexico